Despite weak Q3 earnings, Bharat Petroleum (BPCL) draws attention from global brokerages. CLSA upgraded BPCL to ‘Hold with a ...

The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...

Healthcare stocks see mixed performance as Dr Lal Pathlabs and Aurobindo Pharma rise over 2% after CLSA upgrades their ...

On Thursday, Coupang Inc (CPNG) stock saw a decline, ending the day at $22 which represents a decrease of $-0.25 or -1.12% from the prior close of $22.25. The stock opened at $22.18 and touched a low ...

This steady growth in HDFC Bank's core earnings - both NII and net profit - came in despite a marginal rise in NPAs and NPA ...

Sumeet Jain, senior research analyst at CLSA, shares his outlook for India's IT sector and names his top picks for the space.

CLSA analysts downgraded Dr. Reddy's Laboratories shares, trading on both BSE (DRRD:IN) and NYSE (NYSE:RDY), from a Hold to an Underperform rating, adjusting the price target from INR1,140 to INR1,090 ...

The brokerage firm has also added Zomato to its high conviction outperform list, saying the recent correction is a buying ...

India's most valued company, Reliance Industries Ltd (RIL), reported a robust performance in the third quarter of the current ...

This is the first time Indus Towers has received a ₹575 target, making it the highest among analysts covering the telecom ...

HCLTech declared a dividend of Rs 18 per share, including a special Rs 6 per share dividend to commemorate 25 years since its ...